Radiopharm And Isotopia Announce Supply Agreement For Lutetium-177 N.C.A
14/06/2022 02:14
Radiopharm Theranostics Ltd RAD.AX :
* RADIOPHARM THERANOSTICS LTD - RADIOPHARM AND ISOTOPIA
ANNOUNCE
SUPPLY AGREEMENT FOR LUTETIUM-177 N.C.A
* RADIOPHARM THERANOSTICS - AGREEMENT WILL HELP ADVANCE NEXT
GENERATION OF RADIOPHARMACEUTICAL THERAPIES FOR CANCER TREATMENT
Source text for Eikon: ID:nASX6FFK5F
Further company coverage: RAD.AX
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%